54 drugs in pipeline from 10 companies
54
Drugs in Pipeline
10
Companies
8
Upcoming Catalysts
37
Phase 3 Trials
Ratutrelvir (83-0060) non-randomised Phase 2 Results Expected
Ratutrelvir (83-0060) non-randomised • COVID - 19
Investigational COVID-19 Vaccine Phase 2 Results Expected
Investigational COVID-19 Vaccine • Influenza
Investigational Influenza Vaccine Phase 2 Results Expected
Investigational Influenza Vaccine • Influenza,Human
Efruxifermin Phase 3 Results Expected
Efruxifermin • NASH - Nonalcoholic Steatohepatitis
Trivalent (TIV) messenger ribonucleic acid (mRNA) hemagglutinin (HA) Vaccine 1 Phase 2 Results Expected
Trivalent (TIV) messenger ribonucleic acid (mRNA) hemagglutinin (HA) Vaccine 1 • Influenza
Phathom Pharmaceuticals, Inc.
SINOVAC BIOTECH LTD
EyePoint Pharmaceuticals, Inc.
IRONWOOD PHARMACEUTICALS INC
Sanofi
Aldeyra Therapeutics, Inc.
Kiniksa Pharmaceuticals International, plc
Johnson & Johnson
I-Mab
Dynavax Technologies Corporation
